Design, synthesis and cytotoxic activity of spiro(oxindole-3-3'-pyrrolidine) derivatives
dc.authorid | Ahmet Cenk Andaç / 0000-0002-4545-3500 | en_US |
dc.authorscopusid | Ahmet Cenk Andaç / 20336962400 | |
dc.authorwosid | Ahmet Cenk Andaç / AAW-5539-2020 | |
dc.contributor.author | Konyar, Dilan | |
dc.contributor.author | Andaç, Ahmet Cenk | |
dc.contributor.author | Büyükbingol, Erdem | |
dc.date.accessioned | 2020-08-30T20:07:55Z | en_US |
dc.date.available | 2020-08-30T20:07:55Z | en_US |
dc.date.issued | 2018 | |
dc.department | İstinye Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü | en_US |
dc.description.abstract | Background: Spiro[pyrrolidine-3,3'-oxindole] compounds are reported to be highly bioactive natural and synthetic products. Initially, spirooxindole alkaloids were isolated from plants of the Apocynaceae and Rubiaceae families, which were found to have a common scaffold, spiro[pyrrolidine-3,3'-oxindole], exhibiting anticancer activities., we specifically aimed at the synthesis, characterization and anticancer activity of novel spiro[pyrrolidine-3,3'-oxindole] derivatives, compounds 6a-c and 7. Methods: The synthesis was initiated by Knovenegal condensation of indole-2-one with an appropriate benzaldehyde in presence of piperidine to afford compounds 3a-c. Compounds 6a-c were synthesized by an asymmetric 1,3-dipolar cycloaddition between compounds 3a-c and (2S, 3R)-2, 3, 5, 6-tetrahydro-2, 3-diphenyl-1, 4-oxazin-6-one, which is an intermediate compound formed by the Schiff base reaction between 3-methyl-butanal and (2S, 3R)-2, 3, 5, 6-tetrahydro-2, 3-diphenyl-1,4- oxazin-6-one, in presence of molecular sieves (4A) under argon atmosphere. Compound 6a was then reacted with ethylamine-HCl in THF at room temperature to yield compound 7. Results: Cytotoxic effects of the compounds synthesized were determined on Huh7, MV, HCT116 and MCF7 cancer cell lines by the NCI-60 Sulforhodamine B Assay, using (S)-(+)-Camptothecin as a positive control. In general, target compounds showed better cytotoxic activities against the MCF7 and HCT116 cancer cell lines. It was found that compound 7 exhibited the most potent inhibitory activity with IC50 values of 4.8 mu M, 3.9 mu M, 14.9 mu M and 8.2 mu M against the MCF7, HCT116, MV and Huh7 cell lines, respectively. Conclusion: It was determined that compounds 6a&6b possess C6'(S)|C8'(R)|C9'(R) stereochemistry and compound 7 adopts C2'(S)|C4'(R)|C5'(R) stereochemistry. Cytotoxicity studies suggest that compound 7 gave rise to the highest anticancer activity against MCF7, HCT116, and Huh7 cancer cell lines. | en_US |
dc.description.sponsorship | Research Fund of Ankara UniversityAnkara University [10B3336001] | en_US |
dc.description.sponsorship | This study is funded by the Research Fund of Ankara University (Grant No. 10B3336001). The authors acknowledge Dr. Rengul Atalay at the Cancer System Biology Laboratory, Graduate School of Informatics, Middle East Technical University-Ankara, Turkey, and Deniz Cansen Yildirim at the Department of Molecular Biology and Genetics (DMBG), Faculty of Science, Bilkent University (BU) at Ankara, Turkey, for implementing the cytotoxic activity studies at the DMBG laboratories at BU-Ankara, Turkey. We also would like to thank the Instrumental Analysis Facility in the School of Farmacy at Ankara University-Ankara, Turkey for allowing us to use the NMR, LC-MS and Elemental Analysis instruments therein. | en_US |
dc.identifier.citation | Konyar, D., Andac, C. A., & Buyukbingol, E. (2018). Design, Synthesis and Cytotoxic Activity of Spiro (oxindole-3-3'-pyrrolidine) Derivatives. Letters in Drug Design & Discovery, 15(1), 37-45. | en_US |
dc.identifier.doi | 10.2174/1570180814666170810120634 | en_US |
dc.identifier.endpage | 45 | en_US |
dc.identifier.issn | 1570-1808 | en_US |
dc.identifier.issn | 1875-628X | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.scopus | 2-s2.0-85041688089 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 37 | en_US |
dc.identifier.uri | https://doi.org/10.2174/1570180814666170810120634 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/854 | en_US |
dc.identifier.volume | 15 | en_US |
dc.identifier.wos | WOS:000423790800006 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.institutionauthor | Andaç, Ahmet Cenk | en_US |
dc.language.iso | en | en_US |
dc.publisher | Bentham Science Publ Ltd | en_US |
dc.relation.ispartof | Letters In Drug Design & Discovery | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Oxindole | en_US |
dc.subject | Spiro Pyrrolidino Oxindole | en_US |
dc.subject | 1,3-Dipolar Cycloaddition Reaction | en_US |
dc.subject | Cytotoxic Activity | en_US |
dc.subject | Cancer | en_US |
dc.subject | Drug Design | en_US |
dc.title | Design, synthesis and cytotoxic activity of spiro(oxindole-3-3'-pyrrolidine) derivatives | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- 88.pdf
- Boyut:
- 5.94 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text